Evan Greger is the founder of Pionyr Immunotherapeutics. Pionyr Immunotherapeutics has raised $62M in total funding. Latest round: Series B.
Evan Greger was an early employee at Pionyr Immunotherapeutics, a company focused on developing antibody-based immuno-oncology therapeutics. The company has engaged in contract development and manufacturing projects with partners like ProBioGen and Lonza.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide